Reproductive Issues in BRCA Mutation Carriers

Paluch‐Shimon, Shani; Meirow, Dror; Hyman, Jordana

doi:10.1007/978-3-319-17278-1_7

Cited by 1 publication

(1 citation statement)

References 137 publications

(79 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PGD requires couples to undergo IVF procedures, embryos are cultured in vitro tested using PGD for the BRCA mutation before transferring to the female partner. In this manner, only embryos without BRCA mutation are transferred and a mom-to-be does not have to worry her daughter will have to face dilemmas attribute to BRCA mutation [83,84].…”

Section: Preimplantation Genetic Diagnosis (Pgd)mentioning

confidence: 99%

Fertility preservation in BRCA mutation carriers—efficacy and safety issues: a review

Zhang

Niu

Che

et al. 2020

Reprod Biol Endocrinol

View full text Add to dashboard Cite

BRCA mutation carriers face various situations that influence their fertility potential. There is still a lack of guideline or expert consensus on Fertility Preservation (FP) in BRCA mutation carriers and the necessity and safety of FP in BRCA mutation carriers is still in dispute. This review aims to focus on the population of BRCA mutation carriers by analyzing the existing FP strategies, comprehensively comparing the pros and cons of each strategy and its applicability. FP is a suggestion for BRCA mutation carriers with birth planning. Different FP strategies have different characteristics. Considering the particularity of BRCA mutation carriers, multiple factors need to be carefully considered. This review focuses on the applicability of each FP method for carriers under various circumstances. Available FP strategies including oocyte cryopreservation, ovarian tissue cryopreservation, preimplantation genetic diagnosis, and egg/embryo donation are analyzed by comparing existing methods comprehensively. In the attempt to provide an up-to-date decision-making guidance. Conditions taking into consideration were the carrier's age, the risk of breast and ovarian metastasis, plans for oncotherapy, FP outcome, time available for FP intervention and accessibility. Overall, FP is necessary and safe for BRCA mutation carriers. Among all available FP methods, oocyte cryopreservation is the most reliable procedure; ovarian tissue cryopreservation is the only way for preserving both fertility and endocrine function, recommended for pre-pubertal carriers and when time is limited for oocyte stimulation. A clear framework provides frontline clinical practitioners a new thought and eventually benefit thousands of BRCA mutation carriers.

show abstract

Section: Preimplantation Genetic Diagnosis (Pgd)mentioning

confidence: 99%